---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-023442"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:10:30.414571+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Avalo posts updated investor presentation; no material new facts disclosed

## Summary
- Company posted an updated investor presentation on its website on May 8, 2025.
- Presentation is intended for use in investor meetings; no specific financial or pipeline updates provided in the filing.
- No earnings, clinical data, or guidance changes included in the 8-K or exhibit excerpt.

## SEC filing metadata
- accession: 0001628280-25-023442
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828025023442/0001628280-25-023442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828025023442/avtx-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-023442
- JSON: https://secwatch.observer/filing/0001628280-25-023442.json
- Plain text: https://secwatch.observer/filing/0001628280-25-023442.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.